A Diabetes Crisis in Gaza: Why Insulin Can't Reach Patients Who Need It

A Diabetes Crisis in Gaza: Why Insulin Can't Reach Patients Who Need It
More than 71,000 people in Gaza have diabetes. Of those, roughly 17,500 depend on insulin injections every single day — an amount of medication they cannot survive without. In June 2026, Gaza's Ministry of Health issued a blunt warning: medicine shortages are threatening thousands of lives, and diabetic patients are in particular danger.
This is not about access to a scarce drug. Insulin is cheap and mass-produced worldwide. The problem is purely logistical and political: the insulin exists, but it cannot reach the people who need it.
How the Supply Chain Broke
Gaza operates under a blockade that severely restricts what goods can enter the territory. In December 2023, Human Rights Watch documented that these restrictions were keeping enough medicine out and, just as critically, breaking the cold chain — the system of refrigerated trucks and refrigerated storage that insulin absolutely requires. If insulin gets too warm, it becomes useless, even if it's still in the supply chain.
By March 2026, the World Health Organization reported that medical stocks in Gaza remained critically low. The reason illustrates how fragile the system truly is: even when Israel reopened a key supply route, it was not enough. Trucks need fuel. Warehouses need electricity to run their refrigerators. Staff need to be safe enough to work. Medical convoys need protection to move. The fighting has damaged or destroyed all of these elements.
Throughout 2025 and early 2026, the WHO and UN agencies tracked a consistent pattern: each month's assessment was worse than the last. In May 2025, the WHO said Gaza's health system was at a breaking point. By August 2025, UN agencies warned that children with type 1 diabetes — who have no pill alternative to insulin — were facing severe shortages.
Why Children Face the Worst Outcomes
Type 1 diabetes in children is different from other forms. There is no oral medication. If a child does not receive insulin daily, their body begins to fail. Their blood becomes dangerously acidic. Within days of missed doses, the outcome is organ failure or death.
Managing a child's diabetes requires a careful balance: the right insulin dose, the right amount of food, and consistent physical activity. War destroys that balance. When food is scarce and unpredictable, a child cannot time their meals correctly. When insulin supplies run out, there is no way to improvise. A WHO research report on Gaza's children found that adequate diabetes care has become impossible — compounded by hunger and severe limits on what food is available.
The real human consequence became visible in reporting from late 2023: some diabetic patients in Gaza had gone five days without an insulin injection. That is a medical emergency. The body responds with confusion, then coma, then organ damage.
Why This Crisis Persists
The broader context here matters: this is not happening in isolation. The humanitarian crisis across Palestinian territories deepened throughout 2025, touching everything from food security to water to shelter. A diabetes emergency sits within that larger breakdown.
What is perhaps most striking is that this particular problem has a straightforward technical solution. Experts know exactly what is needed: reliable, temperature-controlled supply corridors. Safe passage for medical trucks. Fuel for hospital generators. These steps are achievable. The gap between what can be done and what is being done is not technical — it is political. Whether the conditions exist for those steps to happen is a question that facts alone cannot answer.
What the documentation does show is a durable pattern of deterioration. The WHO, UN agencies, and human rights groups have all tracked the same problem across two and a half years. With each update, conditions have worsened rather than improved. For Gaza's insulin-dependent patients — including over 1,000 children — that trajectory means a daily reality: rationing doses against an uncertain next supply.


